Delivery Order SPE2DB25D3005-SPE2DB25FQJMF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,160.66 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packages) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a $4,039.86 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for Lo Loestrin Fe 1-10 tablets (quantity: 28-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 3, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,793.99 firm fixed-price delivery order for Lo Loestrin Fe 1-10 tablets (28-count supply) on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,420.05 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation, executed on June 24, 2025, with an ultimate completion date of June 25, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,560.38 to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 Tablet 28s, a hormonal contraceptive medication. The contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,398.34 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count package) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a supply of a brand-name oral contraceptive medication. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,315.26 delivery order to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 Tablet 28s on August 13, 2025, with completion by August 14, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $4,102.40 to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 tablets (28-count packaging) on July 21, 2025, with completion expected by July 22, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location at...
- The Defense Logistics Agency awarded a $2,386.52 delivery order to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packages) on May 20, 2025, with an ultimate completion date of May 21, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,042.64 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count units) on June 2, 2025, with an ultimate completion date of June 3, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.999 billion through December 2026. The order...
- SPE2DB25D3005Indefinite Delivery Contract
- SPE2DB25D3005-SPE2DB25FQJMFDelivery Order
The Defense Logistics Agency awarded a $3,221.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packaging) on September 5, 2025, with completion targeted for September 8, 2025. This contract represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The company maintains an extensive portfolio of federal contracts with the Defense Logistics Agency's Medical Supply Chain, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. This delivery order for Lo Loestrin Fe—a combination oral contraceptive—exemplifies the company's role in fulfilling routine pharmaceutical supply requirements for the Defense Health Agency and other government healthcare entities through the broader global pharmaceutical prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 9/5/25 |